AZTR

Latest SEC Filings & News for AZTR

4 most recent filings and news items mentioning AZTR. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/AZTR/news?limit=20"

Pull AZTR filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Azitra pivots strategy toward synthetic biology and AI-driven therapeutics

CEO Francisco Salva outlined strategic reorientation initiatives following a $10.5M financing in March, expanding beyond precision dermatology into cosmetic ingredients and biotech tools. The company aims to leverage microbial genetic engineering technology to participate in larg

View filing at SEC.gov →

Azitra amends certificate to increase authorized shares to 760M

Azitra increased total authorized shares from an unstated prior amount to 760M shares, comprising 750M common shares and 10M preferred shares. The amendment provides greater flexibility for future equity issuances and capital structure management.

View filing at SEC.gov →

Azitra adjourns 2026 annual meeting to June 15 due to insufficient quorum

Azitra's 2026 Annual Meeting was adjourned from June 4 to June 15 because only 17% of shares were represented, below the required 33.3% quorum threshold. The reconvened virtual meeting allows additional time for stockholder participation and voting on company proposals.

View filing at SEC.gov →

Azitra adjourns June 4 annual meeting to June 15 due to proxy mailing delay

Azitra announced it will convene its 2026 annual stockholder meeting on June 4, 2026, then immediately adjourn and reconvene on June 15, 2026, citing a minor administrative delay in mailing proxy materials. The postponement allows additional time for stockholders to receive and s

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.